Sabby Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Sabby Management’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-37,656	Closed	-$817K	–	103
2023 Q3	$817K	Sell	37,656 -10,605	-22%	-$340K	0.6%	8
2023 Q2	$1.86M	Buy	+48,261	New	+$1.7M	1.52%	4
2023 Q1	–	Sell	-396	Closed	-$13K	–	137
2022 Q4	$13K	Sell	396 -755	-66%	-$55.1K	0.01%	99
2022 Q3	$139K	Sell	1,151 -502	-30%	-$90.4K	0.18%	71
2022 Q2	$289K	Sell	1,653 -344	-17%	-$72.5K	0.2%	58
2022 Q1	$579K	Sell	1,997 -2,338	-54%	-$887K	0.09%	59
2021 Q4	$2.27M	Buy	+4,335	New	+$3.11M	0.33%	51

Other funds holding BIOR

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Sabby Management's BIOR Position: Q4 2023 in Review

Sabby Management sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2023, closing a stake of 37,656 shares — an estimated $817K sold.

Sabby Management first reported a position in BIOR in Q4 2021 and held it in 7 quarters. The position peaked at $2.27M in Q4 2021. 29 funds tracked by Wall St. Rank hold BIOR as of Q4 2023.

Sabby Management reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Sabby Management sold 37,656 Biora Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $817K.
Sabby Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Sabby Management's Biora Therapeutics, Inc. Common Stock position peaked at $2.27M in Q4 2021.
29 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Sabby Management's 13F filing for Q4 2023, filed 14 Feb 2024.